Atrium Innovations Inc. (Public, TSE:ATB) is a developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries. The Company offers its products via healthcare practitioners, health-food stores and pharmacies, or directly to consumers. The Company sells its Pure Encapsulations and Douglas Laboratories brands to healthcare practitioners, such as chiropractors, naturopaths and medical doctors or to select distributors, who then recommend or resell products to their patients while providing information regarding ingredients and applications. It owns three brands in Europe, including Wobenzym in Germany, and Orthica and AOV in the Netherlands. It distributes in Canada through its subsidiary Douglas Laboratories Canada and other distribution partners. In January 2011, the Company acquired Seroyal International.